Cardiac secretion of atrial natriuretic factor with exercise in chronic congestive heart failure patients

R J Cody1, S H Kubo, J H Laragh

  • 1Department of Medicine, New York Hospital-Cornell Medical Center, New York 10021.

Insights

Congestive heart failure (CHF) patients show elevated atrial natriuretic factor (ANF) at rest. Exercise further increases ANF secretion, indicating active myocardial release in CHF patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Physiology

Background:

  • Plasma atrial natriuretic factor (ANF) is significantly elevated in congestive heart failure (CHF) patients.
  • The capacity for increased ANF secretion under physiological stress in CHF remains unclear.

Purpose of the Study:

  • To investigate ANF secretion during ergometric exercise in CHF patients.
  • To determine if myocardial ANF secretion contributes to elevated ANF levels during stress.

Main Methods:

  • Collected peripheral venous ANF samples at rest and peak exercise in 11 CHF patients.
  • Obtained simultaneous peripheral venous and right ventricular ANF samples in 7 patients to assess myocardial secretion.
  • Monitored hemodynamic parameters during exercise.

Main Results:

  • Baseline ANF levels were elevated (108 +/- 58 fmol/ml) and increased significantly with exercise (183 +/- 86 fmol/ml, P < 0.003).
  • Exercise induced significant hemodynamic changes, including increased heart rate, blood pressure, cardiac output, and filling pressures.
  • A notable increase in right ventricular ANF during exercise suggested active myocardial secretion.

Conclusions:

  • CHF patients exhibit increased ANF secretion during exercise, beyond already elevated baseline levels.
  • Active myocardial secretion of ANF occurs during physiological stress in CHF, contributing to systemic levels.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...